CIMATRON LIMITED
|
|||
|
By:
|
/s/ Ilan Erez | |
Ilan Erez
|
|||
Chief Financial Officer
|
|||
Exhibit
No.
|
Description
|
99.1
|
Press release announcing results of operations of Cimatron Limited for the quarter and nine months ended September 30, 2013.
|
|
·
|
45% increase in y-o-y non-GAAP operating profit, to a Q3 record of $1.4 million
|
|
·
|
62% increase in y-o-y non-GAAP net profit, to a Q3 record of $1.1 million
|
|
·
|
Record Q3 revenues of $10.3 million, a 9% y-o-y increase (6% in constant currencies)
|
|
·
|
88% gross margin and 14% operating margin on a non-GAAP basis
|
|
·
|
$0.11 non-GAAP EPS
|
|
·
|
$12.9 million end of quarter net cash balance
|
Company Contact:
Ilan Erez, Chief Financial Officer
Cimatron Ltd.
Tel.; 972-73-237-0114
Email: ilane@cimatron.com
|
Investor Relations contact
Ehud Helft/Kenny Green
CCG Investor Relations
Tel: (US) 1 646 201 9246
Email: Cimatron@ccgisrael.com
|
Three months ended
|
Nine months ended
|
|||||||||||||||
September 30,
|
September 30,
|
|||||||||||||||
2013
|
2012
|
2013
|
2012
|
|||||||||||||
Total revenue
|
10,301 | 9,463 | 31,498 | 29,957 | ||||||||||||
Total cost of revenue
|
1,405 | 1,218 | 4,122 | 3,570 | ||||||||||||
Gross profit
|
8,896 | 8,245 | 27,376 | 26,387 | ||||||||||||
Research and development expenses
|
1,790 | 1,613 | 5,276 | 4,935 | ||||||||||||
Selling, general and administrative expenses
|
5,891 | 5,918 | 18,694 | 18,019 | ||||||||||||
Operating income
|
1,215 | 714 | 3,406 | 3,433 | ||||||||||||
Financial income (expenses), net
|
15 | 41 | (9 | ) | (51 | ) | ||||||||||
Taxes on income
|
(265 | ) | (199 | ) | (834 | ) | (999 | ) | ||||||||
Other
|
(1 | ) | (18 | ) | 4 | (7 | ) | |||||||||
Net income
|
964 | 538 | 2,567 | 2,376 | ||||||||||||
Less: Net income attributable to the noncontrolling interest
|
(9 | ) | (15 | ) | (6 | ) | (24 | ) | ||||||||
Net income attributable to Cimatron's shareholders
|
$ | 955 | $ | 523 | $ | 2,561 | $ | 2,352 | ||||||||
Net income per share - basic and diluted
|
$ | 0.10 | $ | 0.06 | $ | 0.27 | $ | 0.25 | ||||||||
Weighted average number of shares outstanding
|
||||||||||||||||
Basic EPS (in thousands)
|
9,727 | 9,314 | 9,480 | 9,308 | ||||||||||||
Diluted EPS (in thousands)
|
9,740 | 9,331 | 9,488 | 9,325 |
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||||||||||||||||||||||||||
September,
|
September,
|
|||||||||||||||||||||||||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||||||||||||||||||||||||||||
GAAP
|
Adj.
|
NON-GAAP
|
GAAP
|
Adj.
|
NON-GAAP
|
GAAP
|
Adj.
|
NON-GAAP
|
GAAP
|
Adj.
|
NON-GAAP
|
|||||||||||||||||||||||||||||||||||||
Total revenue
|
10,301 | - | 10,301 | 9,463 | - | 9,463 | 31,498 | - | 31,498 | 29,957 | - | 29,957 | ||||||||||||||||||||||||||||||||||||
Total cost of revenue
|
1,405 | 1,258 | 1,218 | 1,071 | 4,122 | 3,681 | 3,570 | 3,548 | ||||||||||||||||||||||||||||||||||||||||
Non-cash amortization of acquired intangible assets
|
(147 | ) | (147 | ) | (441 | ) | (441 | ) | ||||||||||||||||||||||||||||||||||||||||
One-time income from OCS agreement
|
419 | |||||||||||||||||||||||||||||||||||||||||||||||
Gross profit
|
8,896 | 147 | 9,043 | 8,245 | 147 | 8,392 | 27,376 | 441 | 27,817 | 26,387 | 22 | 26,409 | ||||||||||||||||||||||||||||||||||||
Research and development expenses (1)
|
1,790 | (3 | ) | 1,787 | 1,613 | - | 1,613 | 5,276 | (3 | ) | 5,273 | 4,935 | - | 4,935 | ||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses
|
5,891 | 5,861 | 5,918 | 5,819 | 18,694 | 18,579 | 18,019 | 17,723 | ||||||||||||||||||||||||||||||||||||||||
Non-cash amortization of acquired intangible assets
|
- | (99 | ) | (85 | ) | (296 | ) | |||||||||||||||||||||||||||||||||||||||||
Stock-based compensation
|
(30 | ) | - | (30 | ) | - | ||||||||||||||||||||||||||||||||||||||||||
Operating income
|
1,215 | 180 | 1,395 | 714 | 246 | 960 | 3,406 | 559 | 3,965 | 3,433 | 318 | 3,751 | ||||||||||||||||||||||||||||||||||||
Financial income (expenses), net
|
15 | - | 15 | 41 | - | 41 | (9 | ) | - | (9 | ) | (51 | ) | - | (51 | ) | ||||||||||||||||||||||||||||||||
Taxes on income (2)
|
(265 | ) | (34 | ) | (299 | ) | (199 | ) | (90 | ) | (289 | ) | (834 | ) | (125 | ) | (959 | ) | (999 | ) | 28 | (971 | ) | |||||||||||||||||||||||||
Other
|
(1 | ) | - | (1 | ) | (18 | ) | - | (18 | ) | 4 | - | 4 | (7 | ) | - | (7 | ) | ||||||||||||||||||||||||||||||
Net income
|
964 | 146 | 1,110 | 538 | 156 | 694 | 2,567 | 434 | 3,001 | 2,376 | 346 | 2,722 | ||||||||||||||||||||||||||||||||||||
Less: Net income attributable to the noncontrolling interest
|
(9 | ) | - | (9 | ) | (15 | ) | - | (15 | ) | (6 | ) | - | (6 | ) | (24 | ) | - | (24 | ) | ||||||||||||||||||||||||||||
Net income attributable to Cimatron's shareholders
|
$ | 955 | $ | 146 | $ | 1,101 | $ | 523 | $ | 156 | $ | 679 | $ | 2,561 | $ | 434 | $ | 2,995 | $ | 2,352 | $ | 346 | $ | 2,698 | ||||||||||||||||||||||||
Net income per share - basic and diluted
|
$ | 0.10 | $ | 0.11 | $ | 0.06 | $ | 0.07 | $ | 0.27 | $ | 0.32 | $ | 0.25 | $ | 0.29 | ||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding
|
||||||||||||||||||||||||||||||||||||||||||||||||
Basic EPS (in thousands)
|
9,727 | 9,727 | 9,314 | 9,314 | 9,480 | 9,480 | 9,308 | 9,308 | ||||||||||||||||||||||||||||||||||||||||
Diluted EPS (in thousands)
|
9,740 | 9,740 | 9,331 | 9,331 | 9,488 | 9,488 | 9,325 | 9,325 |
(1) Non-GAAP adjustment to exclude stock-based compensation
|
||||||||||||||||||||||
(2) Non-GAAP adjustment to exclude the effect of deferred taxes and other tax provisions.
|
September 30,
|
December 31,
|
|||||||
2013
|
2012
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Total cash, cash equivalents and short-term investments
|
$ | 12,914 | $ | 11,903 | ||||
Trade receivables
|
5,457 | 6,049 | ||||||
Other current assets
|
2,033 | 1,788 | ||||||
Total current assets
|
20,404 | 19,740 | ||||||
Deposits with insurance companies and severance pay fund
|
3,624 | 3,296 | ||||||
Net property and equipment
|
964 | 875 | ||||||
Net other assets
|
10,057 | 10,499 | ||||||
Total assets
|
$ | 35,049 | $ | 34,410 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Short-term bank credit
|
$ | 21 | $ | 1 | ||||
Trade payables
|
1,023 | 1,169 | ||||||
Accrued expenses and other liabilities
|
5,059 | 7,204 | ||||||
Deferred revenues
|
4,802 | 2,843 | ||||||
Total current liabilities
|
10,905 | 11,217 | ||||||
LONG-TERM LIABILITIES:
|
||||||||
Accrued severance pay
|
4,889 | 4,453 | ||||||
Deferred tax liability
|
127 | 275 | ||||||
Total long-term liabilities
|
5,016 | 4,728 | ||||||
Total shareholders’ equity
|
19,128 | 18,465 | ||||||
Total liabilities and shareholders’ equity
|
$ | 35,049 | $ | 34,410 |
Noncontrolling
Interest
|
Share
capital
|
Additional
paid-in capital
|
Accumulated other comprehensive income (loss) |
Retained
earnings
(accumulated
deficit)
|
Treasury
stock
|
Comprehensive
income
(loss)
|
Total
shareholders’
equity
|
|||||||||||||||||||||||||
Balance at December 31, 2012
|
$ | 28 | $ | 313 | $ | 18,906 | $ | (6 | ) | $ | (24 | ) | $ | (752 | ) | $ | 18,465 | |||||||||||||||
Changes during the nine months ended September 30, 2013:
|
||||||||||||||||||||||||||||||||
Net income
|
6 | 2,561 | 2,567 | 2,567 | ||||||||||||||||||||||||||||
Cash distribution to shareholders
|
(7,916 | ) | (7,916 | ) | ||||||||||||||||||||||||||||
Issuance of shares
|
28 | 5,758 | 5,786 | |||||||||||||||||||||||||||||
Issuance of restricted shares
|
9 | 9 | ||||||||||||||||||||||||||||||
Stock based compensation
|
80 | 80 | ||||||||||||||||||||||||||||||
Other
|
73 | 73 | 73 | |||||||||||||||||||||||||||||
Foreign currency translation adjustment
|
64 | 64 | 64 | |||||||||||||||||||||||||||||
Total comprehensive income
|
2,704 | |||||||||||||||||||||||||||||||
Balance at September 30, 2013
|
$ | 34 | $ | 350 | $ | 16,828 | $ | 131 | $ | 2,537 | $ | (752 | ) | $ | 19,128 |
Nine months ended
|
||||||||
September 30,
|
||||||||
2013
|
2012
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$ | 2,567 | $ | 2,376 | ||||
Adjustments to reconcile net income
|
||||||||
to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
796 | 1,007 | ||||||
Increase in accrued severance pay
|
415 | 63 | ||||||
Stock based compensation
|
33 | - | ||||||
Deferred taxes, net
|
(115 | ) | (272 | ) | ||||
Changes in assets and liabilities:
|
||||||||
Decrease in accounts receivable and prepaid expenses
|
332 | 1,051 | ||||||
Increase (decrease) in inventory
|
12 | (2 | ) | |||||
Increase in deposits with insurance companies and severance pay fund
|
(328 | ) | (63 | ) | ||||
Decrease in trade payables, accrued expenses and other liabilities
|
(425 | ) | (1,587 | ) | ||||
Net cash provided by operating activities
|
3,287 | 2,573 | ||||||
Cash flows from investing activities:
|
||||||||
Proceeds from sale of property and equipment
|
- | 1 | ||||||
Purchase of property and equipment
|
(346 | ) | (243 | ) | ||||
Net cash used in investing activities
|
(346 | ) | (242 | ) | ||||
Cash flows from financing activities:
|
||||||||
Short-term bank credit
|
20 | (40 | ) | |||||
Long-term bank credit
|
(3 | ) | (7 | ) | ||||
Cash distribution to shareholders
|
(7,916 | ) | (1,863 | ) | ||||
Proceeds from issuance of shares upon exercise of options
|
47 | 40 | ||||||
Proceeds from issuance of restricted shares
|
9 | - | ||||||
Proceeds from issuance of shares
|
5,786 | - | ||||||
Net cash used in financing activities
|
(2,057 | ) | (1,870 | ) | ||||
Net increase in cash and cash equivalents
|
884 | 461 | ||||||
Effect of exchange rate changes on cash
|
127 | 28 | ||||||
Cash and cash equivalents at beginning of period
|
11,903 | 11,787 | ||||||
Cash and cash equivalents at end of period
|
$ | 12,914 | $ | 12,276 | ||||
Appendix A - Non-cash transactions
|
||||||||
Purchase of property on credit
|
$ | 7 | $ | 5 |